PMID-30140235 – MGF Modulates Inflammatory Cytokines in Muscle Regeneration
Sun KT, Cheung KK, Au SWN, Yeung SS, Bhargava J, Lee D, Bhargava KK, Lee K. Overexpression of mechano-growth factor modulates inflammatory cytokine expression and macrophage resolution in skeletal muscle injury. Front Physiol. 2018;9:999.
Quick Reference
| Property | Value |
|---|---|
| PMID | 30140235 |
| DOI | 10.3389/fphys.2018.00999 |
| Year | 2018 |
| Journal | Frontiers in Physiology |
| Study Type | Animal in vivo |
| Evidence Level | V (Oxford CEBM) |
| Sample | Mouse model of skeletal muscle injury |
| Peptide(s) Studied | PEG-MGF |
Key Findings
- MGF is rapidly upregulated within 1-2 days post-muscle injury, preceding the expression of systemic IGF-IEa, confirming its role as an early injury-response signal
- Macrophages were identified as the predominant cellular source of MGF in the injured muscle microenvironment, not just the damaged myofibers as previously assumed
- MGF modulated inflammatory cytokine expression during muscle regeneration, promoting a shift from pro-inflammatory (M1) to anti-inflammatory/regenerative (M2) macrophage polarization
- The cytokine modulation included downregulation of TNF-alpha and IL-1beta (pro-inflammatory) with concurrent upregulation of IL-10 and TGF-beta (anti-inflammatory/repair-promoting)
- MGF overexpression accelerated the resolution of inflammation and transition to the regenerative phase of muscle healing
- This study establishes MGF as an orchestrator of the inflammatory-to-regenerative transition, not merely a growth factor for satellite cell activation
Study Design
Animal in vivo study using a mouse model of acute skeletal muscle injury (cardiotoxin-induced). MGF expression was tracked temporally post-injury using qRT-PCR and immunohistochemistry. Macrophage populations were characterized by flow cytometry and immunostaining for M1 (iNOS, CD86) and M2 (CD206, Arg1) markers. Cytokine profiling was performed at multiple time points. MGF overexpression was achieved through local plasmid injection to assess gain-of-function effects on inflammatory resolution and regeneration.
Limitations
- Cardiotoxin injury model is a standardized but artificial model that may not fully replicate clinical muscle injuries (tears, contusions, surgical trauma)
- Mouse model may not translate directly to human muscle regeneration kinetics
- MGF overexpression via plasmid injection is not equivalent to exogenous PEG-MGF administration; dosing and pharmacokinetics differ
- The relative contribution of macrophage-derived MGF versus myofiber-derived MGF to overall repair was not fully quantified
- Single injury model does not address chronic or repeated injury scenarios
Clinical Relevance
This study fundamentally reframes MGF from a simple growth factor to an immunomodulatory peptide that orchestrates the inflammatory response to muscle injury. The discovery that macrophages are a major MGF source and that MGF promotes M1-to-M2 macrophage polarization provides a mechanistic rationale for PEG-MGF's role in acute injury recovery protocols. The early upregulation (1-2 days post-injury) suggests that early PEG-MGF administration may be optimal for clinical benefit. The anti-inflammatory cytokine modulation complements the mechanisms of BPC-157 (angiogenic, cytoprotective) and TB-500 (anti-inflammatory, cell migration), supporting the rationale for the Wolverine Stack combination. Relevant to Module 3 (Tissue Repair) and injury recovery protocols.
Related
#research #animal-in-vivo #evidence-level-V #peg-mgf #recovery #musculoskeletal #immune